Related Experiment Video
Updated: Apr 17, 2026
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
MicroRNA dysregulation in uveal melanoma: a new player enters the game
Zheng Li1, Xin Yu1, Jianxiong Shen1
1Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Abstract:
Uveal melanoma is the second most common form of melanoma and a predominant intraocular malignant tumor in adults. The development of uveal melanoma is a multistep process involving genetic and epigenetic alteration of proto-oncogenes and tumor-suppressor genes. Recent discoveries have shed a new light on the involvement of a class of noncoding RNA known as microRNAs (miRNAs) in uveal melanoma. A lot of miRNAs show differential expressions in uveal melanoma tissues and cell lines. Genes coding for these miRNAs have been characterized as novel oncogene and tumor-suppressor genes based on findings that these miRNAs control malignant phenotypes of uveal melanoma cells. Several studies have confirmed that dysregulation of miRNAs promotes cell-cycle progression, confers resistance to apoptosis, and enhances invasiveness and metastasis. Moreover, several miRNAs have also been shown to correlate with uveal melanoma initiation and progression, and thus may be used as biomarkers for early diagnosis and prognosis. Elucidating the biological aspects of miRNA dysregulation may help us better understand the pathogenesis of uveal melanoma and promote the development of miRNA directed-therapeutics against this disease.
Insights
MicroRNAs (miRNAs) play a crucial role in uveal melanoma development by controlling cell growth and spread. Understanding miRNA dysregulation offers new avenues for diagnosing and treating this eye cancer.
Area of Science:
- Oncology
- Molecular Biology
- Ophthalmology
Background:
- Uveal melanoma is a primary intraocular malignancy in adults.
- Its development involves genetic and epigenetic changes in key genes.
- Emerging research highlights the role of microRNAs (miRNAs) in this process.
Purpose of the Study:
- To explore the significance of microRNAs (miRNAs) in uveal melanoma.
- To understand how miRNA dysregulation influences the disease's pathogenesis.
- To identify potential miRNA-based diagnostic and therapeutic strategies.
Main Methods:
- Analysis of differential miRNA expression in uveal melanoma tissues and cell lines.
- Characterization of miRNA genes as oncogenes or tumor suppressors.
- Review of studies linking miRNA dysregulation to malignant phenotypes.
Main Results:
- Numerous miRNAs exhibit altered expression in uveal melanoma.
- These miRNAs regulate cell-cycle progression, apoptosis resistance, invasiveness, and metastasis.
- Specific miRNAs correlate with uveal melanoma initiation and progression.
Conclusions:
- MicroRNA (miRNA) dysregulation is implicated in uveal melanoma pathogenesis.
- miRNAs can function as oncogenes or tumor suppressors in uveal melanoma.
- miRNAs hold promise as biomarkers for early diagnosis and prognosis, and as therapeutic targets.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs